According to a new report from Intel Market Research , the global High Power Lasers market was valued at USD 2.12 billion in 2025 and is projected to reach USD 3.60 billion by 2032 , growing at a robust CAGR of 8.0% during the forecast period (2025–2032). This growth is propelled by the widespread adoption of high-power lasers across various sectors due to their precision, speed, and efficiency in material processing, particularly in the automotive and aerospace industries. The rise in adoption of laser-based manufacturing in emerging economies, coupled with advancements in laser technology that have reduced costs and improved reliability, also contributes significantly. Furthermore, the growing adoption of fiber lasers over CO2 and solid-state lasers, owing to their superior efficiency and lower operational costs, is a notable trend.
Read MoreAccording to a new report from Intel Market Research, the global Optical Cable Filling Compound (OPGW) market was valued at USD 2.39 billion in 2024 and is projected to reach USD 3.37 billion by 2032, growing at a steady CAGR of 4.5% during the forecast period (2025–2032). This expansion is driven by accelerating 5G deployments, extensive smart grid modernization initiatives, and increasing investments in fiber optic infrastructure worldwide.
Read MoreWith models spanning multiple price ranges and use-cases, Lenovo continues to be a solid choice for Pakistani consumers seeking dependable technology.
Read MoreImagine this: a global hotel chain faces a sudden demand surge during a city’s annual tech festival. Rooms sell out within hours, but when the numbers are tallied, profits fall short of expectations. Elsewhere, a digital health startup discovers that a few unnoticed billing gaps are quietly costing it thousands of dollars every month, funds that could have fueled its next phase of growth
Read MoreAccording to a new report from Intel Market Research, the global Afamelanotide market was valued at USD 136.27 million in 2024 and is projected to reach USD 258.01 million by 2032, growing at a robust CAGR of 9.1% during the forecast period (2025–2032). This growth is propelled by the increasing global prevalence of rare phototoxic disorders, heightened awareness about orphan diseases, and advancements in melanocortin-based peptide therapies.
Read More